Reuters logo
BRIEF-G1 Therapeutics Q2 loss per share $1.09‍​
2017年8月9日 / 中午11点39分 / 3 个月前

BRIEF-G1 Therapeutics Q2 loss per share $1.09‍​

Aug 9 (Reuters) - G1 Therapeutics Inc

* G1 Therapeutics reports second quarter 2017 financial results and recent operational highlights

* Qtrly loss per share $1.09‍​

* Estimates that operating expenses will be in range of $55-$60 million for 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below